Gallebo, Mayco P.

HRN: 27-13-61  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/19/2025
05/26/2025
IV
300mg
1hr PTOR, Then Q8hrs
Empiric
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: